ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 33 filers reported holding ASCENDIS PHARMA A/S in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $235,000 | -65.2% | 2,002 | -60.1% | 0.01% | -66.7% |
| Q4 2021 | $675,000 | -69.4% | 5,019 | -70.1% | 0.02% | -69.4% |
| Q2 2021 | $2,209,000 | +145.4% | 16,793 | +140.4% | 0.05% | +145.0% |
| Q1 2021 | $900,000 | -10.4% | 6,984 | +16.1% | 0.02% | +5.3% |
| Q4 2020 | $1,004,000 | -36.0% | 6,018 | -40.8% | 0.02% | -54.8% |
| Q3 2020 | $1,568,000 | +5.5% | 10,163 | +1.1% | 0.04% | -2.3% |
| Q2 2020 | $1,486,000 | +174.2% | 10,049 | +108.7% | 0.04% | +104.8% |
| Q1 2020 | $542,000 | -22.1% | 4,815 | -3.7% | 0.02% | +90.9% |
| Q4 2019 | $696,000 | +82.2% | 5,000 | -77.3% | 0.01% | -35.3% |
| Q1 2015 | $382,000 | – | 22,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 2,003,147 | $225,574,000 | 20.44% |
| RA Capital Management | 4,914,955 | $553,473,000 | 17.48% |
| Sofinnova Investments, Inc. | 1,109,874 | $124,983,000 | 11.56% |
| Eversept Partners, LP | 275,494 | $31,023,379 | 7.71% |
| Avoro Capital Advisors LLC | 1,787,000 | $201,234,000 | 6.79% |
| Orbimed Advisors | 3,287,400 | $370,194,000 | 6.22% |
| Eventide Asset Management | 1,698,648 | $191,285,000 | 6.19% |
| Logos Global Management LP | 120,000 | $13,513,000 | 5.14% |
| Ghost Tree Capital, LLC | 150,000 | $16,892,000 | 4.48% |
| Spyglass Capital Management LLC | 351,388 | $39,570,000 | 4.47% |